Literature DB >> 26017273

Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls.

Matthew W Johnson1, Patrick S Johnson1, Evan S Herrmann1, Mary M Sweeney1.   

Abstract

Individuals with cocaine use disorders are disproportionately affected by HIV/AIDS, partly due to higher rates of unprotected sex. Recent research suggests delay discounting of condom use is a factor in sexual HIV risk. Delay discounting is a behavioral economic concept describing how delaying an event reduces that event's value or impact on behavior. Probability discounting is a related concept describing how the uncertainty of an event decreases its impact on behavior. Individuals with cocaine use disorders (n = 23) and matched non-cocaine-using controls (n = 24) were compared in decision-making tasks involving hypothetical outcomes: delay discounting of condom-protected sex (Sexual Delay Discounting Task), delay discounting of money, the effect of sexually transmitted infection (STI) risk on likelihood of condom use (Sexual Probability Discounting Task), and probability discounting of money. The Cocaine group discounted delayed condom-protected sex (i.e., were more likely to have unprotected sex vs. wait for a condom) significantly more than controls in two of four Sexual Delay Discounting Task partner conditions. The Cocaine group also discounted delayed money (i.e., preferred smaller immediate amounts over larger delayed amounts) significantly more than controls. In the Sexual Probability Discounting Task, both groups showed sensitivity to STI risk, however the groups did not differ. The Cocaine group did not consistently discount probabilistic money more or less than controls. Steeper discounting of delayed, but not probabilistic, sexual outcomes may contribute to greater rates of sexual HIV risk among individuals with cocaine use disorders. Probability discounting of sexual outcomes may contribute to risk of unprotected sex in both groups. Correlations showed sexual and monetary results were unrelated, for both delay and probability discounting. The results highlight the importance of studying specific behavioral processes (e.g., delay and probability discounting) with respect to specific outcomes (e.g., monetary and sexual) to understand decision making in problematic behavior.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017273      PMCID: PMC4445907          DOI: 10.1371/journal.pone.0128641

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  75 in total

1.  Amount of reward has opposite effects on the discounting of delayed and probabilistic outcomes.

Authors:  L Green; J Myerson; P Ostaszewski
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1999-03       Impact factor: 3.051

2.  Area under the curve as a measure of discounting.

Authors:  J Myerson; L Green; M Warusawitharana
Journal:  J Exp Anal Behav       Date:  2001-09       Impact factor: 2.468

3.  Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.

Authors:  Scott F Coffey; Gregory D Gudleski; Michael E Saladin; Kathleen T Brady
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

4.  Opportunity costs of reward delays and the discounting of hypothetical money and cigarettes.

Authors:  Patrick S Johnson; Evan S Herrmann; Matthew W Johnson
Journal:  J Exp Anal Behav       Date:  2014-11-12       Impact factor: 2.468

5.  Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes.

Authors:  Yu Ohmura; Taiki Takahashi; Nozomi Kitamura
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  The role of individual time preferences in health behaviors among hypertensive adults: a pilot study.

Authors:  R Neal Axon; W David Bradford; Brent M Egan
Journal:  J Am Soc Hypertens       Date:  2008-10-31

7.  Sexual discounting among high-risk youth ages 18-24: implications for sexual and substance use risk behaviors.

Authors:  Jacinda K Dariotis; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2014-12-29       Impact factor: 3.157

8.  Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials.

Authors:  Evan S Herrmann; Sarah H Heil; Stacey C Sigmon; Kelly E Dunn; Yukiko Washio; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2012-08-11       Impact factor: 4.492

9.  The role of sexual transmission of HIV infection among injection and non-injection drug users.

Authors:  Steffanie A Strathdee; Susan G Sherman
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

10.  Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women.

Authors:  Evan S Herrmann; Dennis J Hand; Matthew W Johnson; Gary J Badger; Sarah H Heil
Journal:  Drug Alcohol Depend       Date:  2014-07-30       Impact factor: 4.492

View more
  39 in total

1.  Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.

Authors:  Matthew W Johnson; Natalie R Bruner; Patrick S Johnson; Kenneth Silverman; Meredith S Berry
Journal:  Exp Clin Psychopharmacol       Date:  2019-08-01       Impact factor: 3.157

2.  Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV.

Authors:  Matthew W Johnson; Evan S Herrmann; Mary M Sweeney; Robert S LeComte; Patrick S Johnson
Journal:  Psychopharmacology (Berl)       Date:  2016-12-05       Impact factor: 4.530

3.  Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task.

Authors:  Christina S Meade; Daniella M Cordero; Andrea L Hobkirk; Brandon M Metra; Nan-Kuei Chen; Scott A Huettel
Journal:  Hum Brain Mapp       Date:  2016-03-23       Impact factor: 5.038

4.  Using Arousal Suppression Exercises to Decrease Inappropriate Sexual Arousal in Detained Adolescent Males: Three Clinical Demonstrations.

Authors:  Kristen M Brogan; John T Rapp; Amanda M Niedfeld; Kelli R Thompson; Barry R Burkhart
Journal:  Behav Anal Pract       Date:  2020-02-05

Review 5.  Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies.

Authors:  Meredith S Berry; Matthew W Johnson
Journal:  Pharmacol Biochem Behav       Date:  2017-08-24       Impact factor: 3.533

6.  Concordance between monetary and sexual delay discounting in men who have sex with men.

Authors:  Jeb Jones; Jodie L Guest; Patrick S Sullivan; Michael R Kramer; Samuel M Jenness; Jessica M Sales
Journal:  Sex Health       Date:  2018-06       Impact factor: 2.706

7.  Initial feasibility and validity of a prospective memory training program in a substance use treatment population.

Authors:  Mary M Sweeney; Olga Rass; Patrick S Johnson; Eric C Strain; Meredith S Berry; Hoa T Vo; Marc J Fishman; Cynthia A Munro; George W Rebok; Miriam Z Mintzer; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

8.  Discounting of Condom-Protected Sex as a Measure of High Risk for Sexually Transmitted Infection Among College Students.

Authors:  Anahí Collado; Patrick S Johnson; Jennifer M Loya; Matthew W Johnson; Richard Yi
Journal:  Arch Sex Behav       Date:  2016-10-03

9.  Exploring Relationships Among Experience of Regret, Delay Discounting, and Worries About Future Effects of Smoking Among Current Smokers.

Authors:  Richard J O'Connor; James F Thrasher; Maansi Bansal-Travers
Journal:  Subst Use Misuse       Date:  2016-05-18       Impact factor: 2.164

10.  Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sex.

Authors:  Mikhail N Koffarnus; Matthew W Johnson; Daisy G Y Thompson-Lake; Michael J Wesley; Terry Lohrenz; P Read Montague; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.